Evidence map›Paper›PMID 28877936›Full record

Observational studyCancer prevention research (Philadelphia, Pa.)2017

Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.

Ana B Pavel, Joshua D Campbell, Gang Liu, David Elashoff, Steven Dubinett, Kate Smith, Duncan Whitney, Marc E Lenburg, Avrum Spira, AEGIS Study Team

Open access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Cancer prevention research (Philadelphia, Pa.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. A Robust NSCLC Biomarker- miR-7-5p: ItsMicroRNA (Shariqah, United Arab Emirates) · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Advances in applications of artificial intelligence algorithms for cancer-related miRNA research.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis.International journal of chronic obstructive pulmonary disease · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ana B PavelThe Graduate Program in Bioinformatics, Boston University, Boston, Massachusetts. aspira@bu.edu mlenburg@bu.edu anapavel@bu.edu.
Joshua D CampbellThe Graduate Program in Bioinformatics, Boston University, Boston, Massachusetts.
Gang LiuSection of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts.
David ElashoffUniversity of California Los Angeles, Los Angeles, California.
Steven DubinettUniversity of California Los Angeles, Los Angeles, California.
Kate SmithVeracyte, South San Francisco, California.
Duncan WhitneyVeracyte, South San Francisco, California.
Marc E LenburgThe Graduate Program in Bioinformatics, Boston University, Boston, Massachusetts. aspira@bu.edu mlenburg@bu.edu anapavel@bu.edu.
Avrum SpiraThe Graduate Program in Bioinformatics, Boston University, Boston, Massachusetts. aspira@bu.edu mlenburg@bu.edu anapavel@bu.edu.
AEGIS Study Team
Boston University · USUniversity of California, Los Angeles · USVeracyte (United States) · US

Funding

The UCLA - Boston University Lung Cancer Biomarker Development LaboratoryU01CA152751 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M., ELASHOFF, DAVID · 2010 to 2015
$5.0M
NCI NIH HHS U01 CA152751
6 · The paper itself

Abstract

We have previously shown that gene expression alterations in normal-appearing bronchial epithelial cells can serve as a lung cancer detection biomarker in smokers. Given that miRNAs regulate airway gene expression responses to smoking, we evaluated whether miRNA expression is also altered in the bronchial epithelium of smokers with lung cancer. Using epithelial brushings from the mainstem bronchus of patients undergoing bronchoscopy for suspected lung cancer (as part of the AEGIS-1/2 clinical trials), we profiled miRNA expression via small-RNA sequencing from 347 current and former smokers for which gene expression data were also available. Patients were followed for one year postbronchoscopy until a final diagnosis of lung cancer (

Indexed as

Gene Expression Regulation, NeoplasticAgedBiomarkers, TumorBronchiBronchoscopyDown-RegulationEarly Detection of CancerEpithelial CellsFemaleGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansLungLung NeoplasmsMaleMicroRNAsBiomarkers, TumorMicroRNAsRNA, Messenger

Identifiers

PMID28877936
PMCPMC6758560
OpenAlexW2751507925

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.